Search
Descriptor English: Astemizole
Descriptor Spanish: Astemizol
Descriptor astemizol
Scope note: Fármaco antihistamínico ya retirado del mercado en muchos países por sus poco frecuentes, pero potencialmente fatales, efectos colaterales.
Descriptor Portuguese: Astemizol
Descriptor French: Astémizole
Entry term(s): Alermizol
Alonga, Astemizol
Astemina
Astemizol Alonga
Astemizol Ratiopharm
Astesen
Emdar
Esmacen
Fustermizol
Hismanal
Histaminos
Hubermizol
Laridal
Paralergin
R 43 512
R-43-512
R43512
Ratiopharm, Astemizol
Retolen
Rifedot
Rimbol
Romadin
Simprox
Urdrim
Tree number(s): D03.633.100.103.105
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D016589
Scope note: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Anti-Allergic Agents
Histamine H1 Antagonists, Non-Sedating
Registry Number: 7HU6337315
CAS Type 1 Name: 1H-Benzimidazol-2-amine, 1-((4-fluorophenyl)methyl)-N-(1-(2-(4-methoxyphenyl)ethyl)-4-piperidinyl)-
Previous Indexing: Benzimidazoles (1966-1991)
Histamine H1 Receptor Blockaders (1966-1991)
Public MeSH Note: 92; ASTEMIZOLE was indexed under BENZIMIDAZOLES 1981-91
Online Note: use ASTEMIZOLE (NM) to search ASTEMIZOLE 1981-91
History Note: 92; was ASTEMIZOLE (NM) 1981-91
DeCS ID: 30247
Unique ID: D016589
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1992/01/01
Date of Entry: 1991/01/24
Revision Date: 2017/05/24
Astemizole - Preferred
Concept UI M0025303
Scope note Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
Preferred term Astemizole
Astemizol Alonga - Narrower
Concept UI M0434735
Preferred term Astemizol Alonga
Entry term(s) Alonga, Astemizol
Astemizol Ratiopharm - Narrower
Concept UI M0434736
Preferred term Astemizol Ratiopharm
Entry term(s) Ratiopharm, Astemizol
Astesen - Narrower
Concept UI M0434737
Preferred term Astesen
Emdar - Narrower
Concept UI M0434738
Preferred term Emdar
Esmacen - Narrower
Concept UI M0434789
Preferred term Esmacen
Fustermizol - Narrower
Concept UI M0434790
Preferred term Fustermizol
Hismanal - Narrower
Concept UI M0025304
Preferred term Hismanal
Histaminos - Narrower
Concept UI M0434791
Preferred term Histaminos
Hubermizol - Narrower
Concept UI M0434792
Preferred term Hubermizol
Laridal - Narrower
Concept UI M0434793
Preferred term Laridal
Paralergin - Narrower
Concept UI M0434829
Preferred term Paralergin
R-43-512 - Narrower
Concept UI M0353548
Preferred term R-43-512
Entry term(s) R 43 512
R43512
Retolen - Narrower
Concept UI M0434830
Preferred term Retolen
Rifedot - Narrower
Concept UI M0434831
Preferred term Rifedot
Rimbol - Narrower
Concept UI M0434832
Preferred term Rimbol
Romadin - Narrower
Concept UI M0434833
Preferred term Romadin
Simprox - Narrower
Concept UI M0434849
Preferred term Simprox
Urdrim - Narrower
Concept UI M0434850
Preferred term Urdrim
Alermizol - Narrower
Concept UI M0434733
Preferred term Alermizol
Astemina - Narrower
Concept UI M0434734
Preferred term Astemina



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey